Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

June 18, 2024

Pyros Pharmaceuticals receives FDA approval for infantile spasms drug

Pyros Pharmaceuticals has received the US Food and Drug Administration (FDA) approval for VIGAFYDE, marking it as the first and only ready-to-use vigabatrin oral solution, for infantile spasms (IS).

Pyros Pharmaceuticals receives FDA approval for infantile spasms drug